Business Segments · Net Sales
Diabetes Group — Net Sales
Medtronic Diabetes Group — Net Sales increased by 5.2% to $796.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 14.7%, from $694.00M to $796.00M. Over 4 years (FY 2021 to FY 2025), Diabetes Group — Net Sales shows an upward trend with a 6.3% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2015
Last reportedQ1 2026
Rolls up toTotal Revenue
How to read this metric
An increase indicates strong market demand and successful commercial execution, while a decrease signals competitive pressure or market saturation.
Detailed definition
This represents the total revenue generated from the sale of diabetes-related medical devices and services, net of retur...
Peer comparison
Standard revenue metric for any business segment across all industries.
Metric ID:
mdt_segment_diabetes_net_salesHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $527.00M | $572.00M | $585.00M | $584.00M | $514.00M | $541.00M | $556.00M | $570.00M | $619.00M | $578.00M | $610.00M | $640.00M | $693.00M | $647.00M | $686.00M | $694.00M | $784.00M | $721.00M | $757.00M | $796.00M |
| QoQ Change | — | +8.5% | +2.3% | -0.2% | -12.0% | +5.3% | +2.8% | +2.5% | +8.6% | -6.6% | +5.5% | +4.9% | +8.3% | -6.6% | +6.0% | +1.2% | +13.0% | -8.0% | +5.0% | +5.2% |
| YoY Change | — | — | — | — | -2.5% | -5.4% | -5.0% | -2.4% | +20.4% | +6.8% | +9.7% | +12.3% | +12.0% | +11.9% | +12.5% | +8.4% | +13.1% | +11.4% | +10.3% | +14.7% |
Range$514.00M – $796.00M
CAGR+9.1%
Avg YoY Growth+8.0%
Median YoY Growth+10.9%
Current Streak2 quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Medtronic's diabetes group — net sales?
- Medtronic (MDT) reported diabetes group — net sales of $796.00M in Q1 2026.
- How has Medtronic's diabetes group — net sales changed year-over-year?
- Medtronic's diabetes group — net sales increased by 14.7% year-over-year, from $694.00M to $796.00M.
- What is the long-term trend for Medtronic's diabetes group — net sales?
- Over 4 years (2021 to 2025), Medtronic's diabetes group — net sales has grown at a 6.3% compound annual growth rate (CAGR), from $2.31B to $2.96B.
- What does diabetes group — net sales mean?
- Total revenue earned from selling diabetes products after accounting for returns and discounts.